Cytokine and chemokine release upon prolonged mechanical loading of the epidermis

Experimental Dermatology

Volumn 16, Issue 7, 2007, Pages 567-573

  Bronneberg, Debbie ^a   Spiekstra, Sander W ^b   Cornelissen, Lisette H ^a   Oomens, Cees W J ^a   Gibbs, Susan ^b   Baaijens, Frank P T ^a   Bouten, Catlijin V C ^a  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

EpiDerm; Interleukin 8; Interleukin1 ; Interleukin1 receptor antagonist; Pressure ulcer; Tumor necrosis factor

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DEATH; CELL MEMBRANE; CELL VACUOLE; CONTROLLED STUDY; CYTOKINE RELEASE; DECUBITUS; EARLY DIAGNOSIS; EDEMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRESSURE MEASUREMENT; SKIN CULTURE; SKIN DEFECT; SUPERNATANT; TISSUE INJURY;

BIOLOGICAL MARKERS; CELLS, CULTURED; CHEMOKINES; CYTOKINES; EPIDERMIS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1ALPHA; INTERLEUKIN-8; MODELS, BIOLOGICAL; PRESSURE; PRESSURE ULCER; STRESS, MECHANICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34250716335     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2007.00566.x     Document Type: Article

References (43)

1. American Pressure Ulcer Advisory Panel. Pressure ulcers prevalence, cost and risk assessment: Consensus development conference statement. Decubitus 1998: 2: 24-28.
2. Peirce S M, Skalak T C, Rodeheaver G T. Ischemia-reperfusion injury in chronic pressure ulcer formation: A skin model in the rat. Wound Repair Regen 2000: 8: 68-76.
3. Bouten C V, Oomens C W, Baaijens F P, Bader D L. The etiology of pressure ulcers: Skin deep or muscle bound? Arch Phys Med Rehabil 2003: 84: 616-619.
4. Bours G J, Halfens R J, Abu-Saad H H, Grol R T. Prevalence, prevention, and treatment of pressure ulcers: Descriptive study in 89 institutions in the Netherlands. Res Nurs Health 2002: 25: 99-110.
5. Schoonhoven L, Haalboom J R, Bousema M T et al. The prevention and pressure ulcer risk score evaluation study. Prospective cohort study of routine use of risk assessment scales for prediction of pressure ulcers. BMJ 2002: 325: 797.
6. Schoonhoven L. Prediction of pressure ulcers: Problems and prospects, [dissertation]. Utrecht: Utrecht University, 2003.
7. Bronneberg D, Bouten C V C, Oomens C W J, van Kemenade P M, Baaijens F P T. An in vitro model system to study the damaging effects of prolonged mechanical loading of the epidermis. Ann Biomed Eng 2006: 34: 506-514.
8. Uchi H, Terao H, Koga T, Furue M. Cytokines and chemokines in the epidermis. J Dermatol Sci 2000: 24: S29-S38.
9. Lee R T, Briggs W H, Cheng G C, Rossiter H B, Libby P, Kupper T. Mechanical deformation promotes secretion of IL-1 α and IL-1 receptor antagonist. J Immunol 1997: 159: 5084-5088.
10. Dinarello C A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 1998: 16: 457-499.
11. Wood L C, Elias P M, Calhoun C, Tsai J C, Grunfeld C, Feingold K R. Barrier disruption stimulates interleukin-1 α expression and release from a preformed pool in murine epidermis. J Invest Dermatol 1996: 106: 397-403.
12. Corsini E, Bruccoleri A, Marinovich M, Galli C L. Endogenous interleukin-1 α associated with skin irritation induced by tributyltin. Toxicol Appl Pharmacol 1996: 138: 268-274.
13. Corsini E, Galli C L. Cytokines and irritant contact dermatitis. Toxicol Lett 1998: 28: 102-103, 277-282.
14. Faller C, Bracher M. Reconstructed skin kits: Reproducibility of cutaneous irritancy testing. Skin Pharmacol Appl Skin Physiol 2002: 15: 74-91.
15. Gibbs S, Vietsch H, Meier U, Ponec M. Effect of skin barrier competence on SLS and water-induced IL-1 α expression. Exp Dermatol 2002: 11: 217-223.
16. Kock A, Schwarz T, Kirnbauer R et al. Human keratinocytes are a source for tumor necrosis factor α: Evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990: 172: 1609-1614.
17. Spiekstra S W, Toebak M J, Sampat-Sardjoepersad S et al. Induction of cytokine (interleukin-1 α and tumor necrosis factor- α) and chemokine (CCL20, CCL27, and CXCL8) damage signals after allergen and irritant exposure. Exp Dermatol 2005: 14: 109-116.
18. Netzlaff F, Lehr C M, Wertz P W, Schaefer U F. The human epidermis models EpiSkin, SkinEthic and EpiDerm: An evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur J Pharm Biopharm 2005: 60: 167-178.
19. Kanj L F,Wilking S V, Phillips T J. Pressure ulcers. J Am Acad Dermatol 1998: 38: 517-536.
20. Wang Y N, Sanders J E. Skin model studies. In: Bader D L, Bouten C V C, Colin D, Oomens C W J, eds. Pressure Ulcer Research, Heidelberg: Springer-Verlag, 2005: 263-285.
21. Swain Y. The measurement of interface pressure. In: Bader D L, Bouten C V C, Colin D, Oomens C W J, eds. Pressure Ulcer Research. Heidelberg: Springer-Verlag, 2005: 51-88.
22. Cannon C L, Neal P J, Southee J A, Kubilus J, Klausner M. New epidermal model for dermal irritancy testing. Toxicol in vitro 1994: 8: 889-891.
23. Goldstein B, Sanders J. Skin response to repetitive mechanical stress: A new experimental model in pig. Arch Phys Med Rehabil 1998: 79: 265-272.
24. Ponec M, Boelsma E, Gibbs S, Mommaas M. Characterization of reconstructed skin models. Skin Pharmacol Appl Skin Physiol 2002: 15: 4-17.
25. Daniel R K, Priest D L, Wheatley D C. Etiologic factors in pressure sores: An experimental model. Arch Phys Med Rehabil 1981: 62: 492-498.
26. Reddy N P, Cochran G H. Interstitial fluid flow as a factor in decubitus ulcer formation. J Biomech 1981: 14: 879-881.
27. Elias P M, Friend D S. The permeability barrier in mammalian epidermis. J Cell Biol 1975: 65: 180-191.
28. Cobb J P, Hotchkiss R S, Karl I E, Buchman T G. Mechanisms of cell injury and death. Br J Anaesth 1996: 77: 3-10.
29. Decker T, Lohmann-Matthes M L. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular toxicity and tumor necrose factor (TNF) activity. J Immunol Methods 1998: 15: 61-69.
30. Legrand C, Bour J M, Jacob C M et al. Lactate dehydrogenase (LDH) activity of the cultured eukaryotic cells as marker of the number of dead cells in the medium. J Biotechnol 1992: 25: 231-243.
31. Ponec M, Kempenaar J. Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants. Skin Pharmacol 1995: 8: 49-59.
32. Edsberg L E, Mates R E, Baier R E, Lauren M. Mechanical characteristics of human skin subjected to static versus cyclic normal pressures. J Rehabil Res Dev 1999: 36: 133-141.
33. Takei T, Kito H, Du W, Mills I, Sumpio B E. Induction of interleukin (IL)-1 alpha and beta gene expression in human keratinocytes exposed to repetitive strain: Their role in strain-induced keratinocyte proliferation and morphological change. J Cell Biochem 1998: 69: 95-103.
34. Bernhofer L P, Barkovic S, Appa Y, Martin K M. IL-1 α and IL-1RA secretion form epidermal equivalents and the prediction of the irritation potential of mild soap and surfactant based consumer products. Toxicol in vitro 1999: 13: 231-239.
35. Flint M S, Dearman R J, Kimber I, Hotchkiss S A. Production and in situ localization of cutaneous tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6) following skin sensitization. Cytokine 1998 6: 213-219.
36. Nickoloff B J, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 1994: 30: 535-546.
37. Oxholm A, Oxholm P, Staberg B, Bendtzen K. Immunohistological detection of interleukin I-like molecules and tumour necrosis factor in human epidermis before and after UVB-irradiation in vivo. Br J Dermatol 1988: 118: 369-376.
38. Wood L C, Jackson S M, Elias P M, Grunfeld C, Feingold K R. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 1992: 90: 482-487.
39. Wood L C, Stalder A K, Liou A et al. Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin. Exp Dermatol 1997: 6: 98-104.
40. Nakayama T, Fujisawa R, Yamada H et al. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 α/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int Immunol 2001: 13: 95-103.
41. Steude J, Kulke R, Christophers E. Interleukin-1-stimulated secretion of interleukin-8 and growth-related oncogene- α demonstrates greatly enhanced keratinocyte growth in human raft cultured epidermis. J Invest Dermatol 2002: 119: 1254-1260.
42. Tohyama M, Shirakara Y, Yamasaki K, Sayama K, Hashimoto K. Differentiated keratinocytes are responsible for TNF- α regulated production of macrophage inflammatory protein 3 α/CCL20, a potent chemokine for Langerhans cells. J Dermatol Sci 2001: 27: 130-139.
43. Wetzler C, Kampfer H, Pfeilschifter J, Frank S. Keratinocyte-derived chemotactic cytokines: Expressional modulation by nitric oxide in vitro and during cutaneous wound repair in vivo. Biochem Biophys Res Commun 2000: 274: 689-696.